CME Downgraded to “Sell” at Goldman Sachs (CME)

By
A A A
Share |

Goldman Sachs reported on Monday that they have downgraded electronic trading exchange, CME Group Inc( CME ) to a "Sell."

The firm reported that they have downgraded CME from "Neutral" to "Sell," and have decreased its price target from $53 to $48. This price target suggests a 14.5% decline from the stock's current price of $54.96.

Analysts see the company starting to focus less on dividends, and more on weak fundamentals. The firm believes that EPS will drop; and also noted company's valuation is stretched due to their change in dividend policies.

CME Group shares were down 99 cents, or -1.80% during premarket trading Monday. The stock is up 12% YTD.

The Bottom Line
Shares of CME Group ( CME ) have a 3.28% dividend yield, based on Friday's closing stock price of $54.96. The stock has technical support in the $50-$52 price area. If the shares can firm up, we see overhead resistance around the $58-$59 price levels.

CME Group Inc( CME ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Created by Dividend.com


This article appears in: Investing , Stocks

Referenced Stocks: CME

Dividend.com

Dividend.com

More from Dividend.com:

Related Videos

Stocks

Referenced

67%

Most Active by Volume

85,384,682
  • $38.63 ▼ 5.62%
85,005,479
  • $17.03 ▲ 0.47%
52,429,793
  • $89.86 ▼ 4.29%
37,253,252
  • $5.165 ▼ 3.46%
36,498,467
  • $100.72 ▼ 0.24%
36,081,555
  • $11.34 ▼ 5.50%
33,433,924
  • $29.73 ▲ 0.68%
32,486,982
  • $98.67 ▼ 1.31%
As of 9/22/2014, 02:30 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com